ACR 2016 Pharma Reports for AS, Gout, PsA and RA
In this article, we highlight some of the most important pharma reports presented at ACR 2016 this year.
Gout Patients Face a Higher Risk for Advanced Kidney Disease
Gout patients who successfully respond to urate lowering therapy have higher rates of chronic kidney disease improvement, a study shows.
High Mortality Rates for Gout Steady Over 16 Years
Gout and rheumatoid arthritis are both associated with premature mortality, researchers report.
Gout Guidelines Give Good Grades
New evidence-based clinical practice guidelines offer some strong—and not so strong—recommendations for effective gout diagnosis and treatment.
Gout Drugs Compared Side-by-Side
Researchers rank febuxostat as the most effective urate-lowering drug for reaching serum uric acid targets for gout patients.
Doctors Don’t Always Agree on Gout’s Origins and Treatment
How do rheumatologists and primary care physicians differ in treating patients with gout? This survey highlights some notable differences.
The Effects of Low GI and Carb Foods on Gout Flares
Gout’s relationship with food intake can be tricky, so which is better: Eating foods lower on the glycemic index scale or lower in carbohydrates?
By clicking Accept, you agree to become a member of the UBM Medica Community.